NCT01171352

Brief Summary

Currently, decisions regarding volume management for dialysis sessions in the ICU are made in large part on the nephrologists'/intensivists' overall gestalt. This gestalt is based upon a combination of commonly used measures of circulatory function, the physical exam, fluid balance, estimates of dialysis dry weight, and monitoring changes in relative blood volume status using devices such as the Crit-Line™ III, and central venous pressures. However, these tools perform poorly in predicting the circulatory system's overall response to dialysis. Consequently, episodes of dangerously low blood pressure are still frequently encountered. Better techniques to predict the circulatory system's response to dialysis are much needed. The intent of this study is to test newer metrics of circulatory system function for their ability to predict low blood pressure episodes during dialysis. This is important because it may enable the design of newer treatment strategies created to prevent low blood pressure episodes during dialysis and improve patient outcomes. The investigators overall hypothesis is that newer measures of vascular volume and dynamic indices of fluid responsiveness, previously found to better reflect cardiac preload state than currently used parameters, will better predict low blood pressure episodes during dialysis than current methods.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2010

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 19, 2010

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

July 27, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 28, 2010

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 11, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 11, 2013

Completed
Last Updated

June 5, 2019

Status Verified

June 1, 2019

Enrollment Period

2.6 years

First QC Date

July 27, 2010

Last Update Submit

June 3, 2019

Conditions

Keywords

hemodialysisdialysishypotensionCritLinePiCCOThermodilutionCVVHDFIHD

Outcome Measures

Primary Outcomes (1)

  • hypotensive episode

    A mean arterial pressure of \<60 mmHg, a 15% decrease from baseline systolic blood pressure at the start of the dialysis treatment regardless of modality, the need for fluid bolusing \>7 mL/kg body weight, or initiation or increase of vasopressor medication in order to maintain MAP \>60 mmHg.

    during or within one hour post dialysis

Secondary Outcomes (6)

  • fluid removal tolerance

    during the 4 hours following parameter measurement in dialysis

  • predicted volume of fluid that can be removed without hypotensive events

    during dialysis

  • mortality in the ICU

    duration of ICU stay

  • All cause mortality

    30 days

  • Length of stay in ICU

    ICU stay duration

  • +1 more secondary outcomes

Study Arms (1)

ICU Dialysis Patients

Any patient 18 years and older who is admitted to the OHSU Hospitals ICUs with ARF, or End Stage Renal Disease (ESRD) for a diagnosis other than hyperkalemia, as the sole determinant for that level of care, will be invited to participate. The patient must have acute or chronic needs for dialytic support during their ICU stay.

Procedure: Transpulmonary Thermodilution

Interventions

A PiCCO femoral catheter will be placed and PiCCO parameters will be obtained using transpulmonary thermodilution after continuous dialysis is ordered or just prior to initiation of intermittent dialysis, hourly until either completion of intermittent dialysis or 8 hours of continuous dialysis is completed.

Also known as: Pulsion Medical Systems, PiCCO2, PiCCO
ICU Dialysis Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Any patient 18 years and older who is admitted to the OHSU Hospitals ICUs with ARF, or End Stage Renal Disease (ESRD) for a diagnosis other than hyperkalemia, as the sole determinant for that level of care, will be invited to participate. The patient must have acute or chronic needs for dialytic support during their ICU stay in order to qualify for the study. Dialysis support may be provided by intermittent HD sessions, or continuous venovenous hemodiafiltration (CVVHDF) depending on the underlying hemodynamic stability of the patient.

You may qualify if:

  • Admitted to OHSU Hospitals ICUs
  • Patient has acute or chronic needs for intermittent hemodialysis support during their ICU stay for any reason other than isolated hyperkalemia
  • Central venous access in place separate from the dialysis catheter, or arteriovenous fistula or graft
  • Two or more organ systems affected by critical illness requiring supportive care as documented in the medical chart.

You may not qualify if:

  • age younger than 18 years old
  • Weight \> 160 kg
  • burns greater than 40% total body surface area
  • known cardiac or vascular aneurysm
  • contraindications to femoral arterial puncture
  • diagnosis of peripheral vascular disease
  • not committed to full support
  • participation in other experimental medication trial within 30 days
  • current atrial or ventricular arrhythmias
  • history of sever CHF- NYHA class \>= III, previously documented EF \< 30%
  • severe aortic regurgitation
  • anticipated ICU stay \< 24 hrs
  • not expected to require dialysis \> 48 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oregon Health and Science University

Portland, Oregon, 97239, United States

Location

Related Publications (16)

  • U.S. Renal Data System, USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. In: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2008.

    BACKGROUND
  • Higgins TL, Teres D, Copes WS, Nathanson BH, Stark M, Kramer AA. Assessing contemporary intensive care unit outcome: an updated Mortality Probability Admission Model (MPM0-III). Crit Care Med. 2007 Mar;35(3):827-35. doi: 10.1097/01.CCM.0000257337.63529.9F.

    PMID: 17255863BACKGROUND
  • Rocha E, Soares M, Valente C, Nogueira L, Bonomo H Jr, Godinho M, Ismael M, Valenca RV, Machado JE, Maccariello E. Outcomes of critically ill patients with acute kidney injury and end-stage renal disease requiring renal replacement therapy: a case-control study. Nephrol Dial Transplant. 2009 Jun;24(6):1925-30. doi: 10.1093/ndt/gfn750. Epub 2009 Jan 22.

    PMID: 19164319BACKGROUND
  • Uchino S, Morimatsu H, Bellomo R, Silvester W, Cole L. End-stage renal failure patients requiring renal replacement therapy in the intensive care unit: incidence, clinical features, and outcome. Blood Purif. 2003;21(2):170-5. doi: 10.1159/000069156.

    PMID: 12601260BACKGROUND
  • Daugirdas JT. Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis. 2001 Oct;38(4 Suppl 4):S11-7. doi: 10.1053/ajkd.2001.28090.

    PMID: 11602456BACKGROUND
  • Goedje O, Seebauer T, Peyerl M, Pfeiffer UJ, Reichart B. Hemodynamic monitoring by double-indicator dilution technique in patients after orthotopic heart transplantation. Chest. 2000 Sep;118(3):775-81. doi: 10.1378/chest.118.3.775.

    PMID: 10988202BACKGROUND
  • Krepel HP, Nette RW, Akcahuseyin E, Weimar W, Zietse R. Variability of relative blood volume during haemodialysis. Nephrol Dial Transplant. 2000 May;15(5):673-9. doi: 10.1093/ndt/15.5.673.

    PMID: 10809809BACKGROUND
  • Davenport A. Can advances in hemodialysis machine technology prevent intradialytic hypotension? Semin Dial. 2009 May-Jun;22(3):231-6. doi: 10.1111/j.1525-139X.2009.00614.x.

    PMID: 19572996BACKGROUND
  • Sakka SG, Reinhart K, Meier-Hellmann A. Comparison of pulmonary artery and arterial thermodilution cardiac output in critically ill patients. Intensive Care Med. 1999 Aug;25(8):843-6. doi: 10.1007/s001340050962.

    PMID: 10447543BACKGROUND
  • Michard F, Alaya S, Zarka V, Bahloul M, Richard C, Teboul JL. Global end-diastolic volume as an indicator of cardiac preload in patients with septic shock. Chest. 2003 Nov;124(5):1900-8. doi: 10.1378/chest.124.5.1900.

    PMID: 14605066BACKGROUND
  • Michard F, Teboul JL. Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest. 2002 Jun;121(6):2000-8. doi: 10.1378/chest.121.6.2000.

    PMID: 12065368BACKGROUND
  • Phillips CR, Watters JM, Hagg DS, et al. Global end-diastolic volume as an indicator of cardiac preload in hemorrhagic shock and resuscitation in swine. Critical Care 2008;12(Suppl 2):P104.

    BACKGROUND
  • Phillips CR, Vinecore K, Hagg DS, Sawai RS, Differding JA, Watters JM, Schreiber MA. Resuscitation of haemorrhagic shock with normal saline vs. lactated Ringer's: effects on oxygenation, extravascular lung water and haemodynamics. Crit Care. 2009;13(2):R30. doi: 10.1186/cc7736. Epub 2009 Mar 4.

    PMID: 19257901BACKGROUND
  • Michard F, Boussat S, Chemla D, Anguel N, Mercat A, Lecarpentier Y, Richard C, Pinsky MR, Teboul JL. Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med. 2000 Jul;162(1):134-8. doi: 10.1164/ajrccm.162.1.9903035.

    PMID: 10903232BACKGROUND
  • De Backer D, Heenen S, Piagnerelli M, Koch M, Vincent JL. Pulse pressure variations to predict fluid responsiveness: influence of tidal volume. Intensive Care Med. 2005 Apr;31(4):517-23. doi: 10.1007/s00134-005-2586-4. Epub 2005 Mar 8.

    PMID: 15754196BACKGROUND
  • Reddan DN, Szczech LA, Hasselblad V, Lowrie EG, Lindsay RM, Himmelfarb J, Toto RD, Stivelman J, Winchester JF, Zillman LA, Califf RM, Owen WF Jr. Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. J Am Soc Nephrol. 2005 Jul;16(7):2162-9. doi: 10.1681/ASN.2004121053. Epub 2005 Jun 1.

    PMID: 15930095BACKGROUND

MeSH Terms

Conditions

Hypotension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Charles R Phillips, MD

    Oregon Health and Science University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 27, 2010

First Posted

July 28, 2010

Study Start

July 19, 2010

Primary Completion

March 11, 2013

Study Completion

March 11, 2013

Last Updated

June 5, 2019

Record last verified: 2019-06

Locations